Trial Profile
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Sponsors Abbott Vascular
- 07 Dec 2015 New trial record